Product Description: Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]World Health Organization. WHO Drug Information 2020, vol. 34, 1 [full issue]. WHO Drug Information, 2020, 34(1): 3-141.
CAS Number: 1826020-80-7
Molecular Weight: N/A
Compound Purity: 97.94
Research Area: Cancer
Solubility: H2O
Target: Others